BC

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment is a comprehensive forum dedicated to all aspects of breast cancer research. Its focus spans surgery, radiotherapy, medical oncology, endocrinology, epidemiology, immunology, and cell biology, and it provides an international platform for latest research, discussion of ongoing controversies in breast cancer treatment, and management guidelines.

Looking to publish in Breast Cancer Research and Treatment? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Oncology
Impact Factor 3
Quartile Q2
Open Access Type Hybrid
ISSN 0167-6806
eISSN 1573-7217
Invitation Only No
Cost Range Open access APC: £2790.00 GBP / $4390.00 USD / €3290.00 EUR; subscription publishing: no APC charges apply.

Submission Instructions

Breast Cancer Research and Treatment accepts the following article types. Click on an article type to view submission instructions.

Original Laboratory Investigations

Cover Letter Cover Letter requirements are not specified.
Abstract A structured abstract is required. Abstract must be 150 to 250 words long. Abstract must be structured. Abstract must be divided into Purpose, Methods, Results, and Conclusion sections.
Manuscript Manuscript should not exceed 3500 words excluding the abstract, title page, tables and figures, and references. Manuscript must include 4 to 6 keywords, a Data Availability Statement, a disclosure statement, documentation of any large language model use in the Methods or another suitable section, and a section headed 'Statements and Declarations' or 'Declarations' including Funding, Competing Interests, and Author Contributions.
References Citations must use numbered references in square brackets. References must be numbered consecutively, include only works cited in the text that have been published or accepted for publication, and include full DOI links when available.
Figures & Tables Figures should be submitted within the body of the text unless file size causes upload problems, in which case large figures should be submitted separately. Tables and figures must be numbered with Arabic numerals and cited in the text in consecutive numerical order, each table must have a caption, and each figure must have a concise caption included in the manuscript text file rather than in the figure file.
Reformat to Breast Cancer Research and Treatment using Livewrite Premium

Clinical Studies

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract must be 150 to 250 words long. Abstract must be structured. Abstract must be divided into Purpose, Methods, Results, and Conclusion, and the last line must include the trial registration number and date of registration, adding 'retrospectively registered' for trials not registered prospectively.
Manuscript Manuscript should not exceed 3500 words, excluding the abstract, title page, tables and figures, and references. Manuscript must include a section headed 'Statements and Declarations' or 'Declarations' and use no more than three levels of displayed headings. Manuscript must provide 4 to 6 keywords, include a disclosure statement, document any large language model use in the Methods section or a suitable alternative, and include a Data Availability Statement for original research articles.
References References must be cited in the text by numbers in square brackets and listed consecutively in numerical order, including only works cited in the text that have been published or accepted for publication.
Figures & Tables Figures should be submitted within the body of the text unless file size causes upload problems, in which case large figures should be submitted separately from the text. Tables and figures must be numbered with Arabic numerals, cited in the text in consecutive numerical order, and accompanied by captions, with figure captions included in the manuscript text file rather than in the figure files.
Reformat to Breast Cancer Research and Treatment using Livewrite Premium

Translational Studies

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required and must be structured. Abstract must be 150 to 250 words long. Abstract must be structured. Abstract must be divided into Purpose, Methods, Results, and Conclusion sections.
Manuscript Manuscript text should not exceed 3500 words, excluding the abstract, title page, tables and figures, and references. Use of a specific overall manuscript structure is not explicitly stated beyond required abstract sections. Manuscript must include 4 to 6 keywords, a Data Availability Statement, a disclosure statement, a section headed 'Statements and Declarations' after the References section including Funding, Competing Interests, and Author Contributions statements, and documentation of any large language model use in the Methods section or a suitable alternative section.
References Citations must be numbered in square brackets in the text, and the reference list must contain only cited works published or accepted for publication, numbered consecutively, with full DOI links when available.
Figures & Tables Figures should be submitted within the body of the text unless file size causes upload problems, in which case large figures should be submitted separately. Tables and figures must be numbered with Arabic numerals and cited in consecutive numerical order, each table must have a caption, and each figure must have a concise caption included in the manuscript text file rather than in the figure file.
Reformat to Breast Cancer Research and Treatment using Livewrite Premium

Reviews

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required and must be structured. Abstract must be 150 to 250 words long. Abstract must be structured. Abstract must be divided into Purpose, Methods, Results, and Conclusion sections.
Manuscript Manuscript should not exceed 3500 words, excluding the abstract, title page, tables and figures, and references. Manuscript must include a title page with the title, author names, affiliations, and corresponding author email. Manuscript must include 4 to 6 keywords, a section headed 'Statements and Declarations' or 'Declarations,' documentation of any large language model use in the Methods or a suitable alternative section, a review-specific statement identifying who conceived the article, performed the literature search and data analysis, and drafted and/or critically revised the work, and a disclosure statement.
References References must be cited in the text using numbers in square brackets and listed consecutively in the reference list with full DOI links when available.
Figures & Tables Figures should be submitted within the body of the text unless file size causes upload problems, in which case large figures should be submitted separately. Tables and figures must be numbered with Arabic numerals, cited in consecutive numerical order, and accompanied by captions, with figure captions included in the manuscript text file rather than in the figure files.
Reformat to Breast Cancer Research and Treatment using Livewrite Premium

Meta-Analyses Papers

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract must be 150 to 250 words long. Abstract must be structured. Abstract must be divided into Purpose, Methods, Results, and Conclusion sections.
Manuscript Manuscript must not exceed 3500 words, excluding the abstract, title page, tables and figures, and references. Manuscript must include a disclosure statement and a section headed either 'Statements and Declarations' after the references or 'Declarations' before the reference list containing Funding, Competing Interests, and Author Contributions statements, and any use of a large language model must be documented in the Methods section or a suitable alternative section.
References Citations must be numbered in square brackets in the text and the reference list must be numbered consecutively and include only cited works that have been published or accepted for publication, with full DOI links when available.
Figures & Tables Figures should be submitted within the body of the text unless file size causes upload problems, in which case large figures should be submitted separately from the text. Tables and figures must be numbered with Arabic numerals, cited in the text in consecutive numerical order, and accompanied by captions, with figure captions included in the manuscript text file rather than in the figure files.
Reformat to Breast Cancer Research and Treatment using Livewrite Premium

Letter To The Editor

Cover Letter Cover Letter requirements are not specified.
Abstract Letter To The Editor submissions must not include an abstract.
Manuscript Letter To The Editor manuscript body text is limited to 750 words. Provide a section headed 'Statements and Declarations' after the references section including Funding, Competing Interests, and Author Contributions statements, and document any use of a large language model in a suitable section of the manuscript.
References Letter To The Editor submissions may include up to 3 references. Citations must be numbered in square brackets in the text, and the reference list must be numbered consecutively and include only works cited in the text that have been published or accepted for publication.
Figures & Tables Letter To The Editor submissions may include 1 figure. Figures should be submitted within the body of the text unless file size causes upload problems, in which case they should be submitted separately. Figures must be numbered with Arabic numerals, cited in consecutive numerical order, and accompanied by concise captions provided in the manuscript text file.
Reformat to Breast Cancer Research and Treatment using Livewrite Premium

Recent Publications

Predictors of pathologic complete response in early-stage triple-negative breast cancer treated with neoadjuvant chemo-immunotherapy: a multi-institution study

Alexis LeVee, Bethania Santos, Megan Wong, Nora Ruel, Daniel Schmolze, Irene Kang, Karen Tsai, Joanne Mortimer, Heather McArthur

10.1007/s10549-026-07984-8
View Publication

Non-BRCA germline pathogenic variants and response to neoadjuvant systemic therapy in triple-negative breast cancer patients enrolled in a prospective clinical trial

Kamaria L. Lee, Clinton Yam, Li Zhao, Roland L. Bassett, Xingzhi Song, Alastair M. Thompson, Jason B. White, Rachel M. Layman, Lei Huo, Angelica M. Gutierrez, Vicente Valero, Naoto T. Ueno, Jennifer K. Litton, Jianhua Zhang, Elizabeth Ravenberg, Anil Korkut, Beatriz E. Adrada, Rosalind P. Candelaria, Gaiane M. Rauch, Debu Tripathy, Simona F. Shaitelman, Banu K. Arun

10.1007/s10549-026-07985-7
View Publication

Association of cumulative lifetime estrogen exposure and reproductive factors with breast cancer molecular subtype among Nigerian women in the MEND study

Jovita Byemerwa, Drew Neish, Ebunoluwa Olunuga, Oyomoare Osazuwa-Peters, April Deveaux, Ashwini Joshi, Omolola Salako, Adetola Daramola, Olusegun Alatise, Gabriel Ogun, Allison Hall, Adewale Adeniyi, Omobolaji Ayandipo, Thomas Olajide, Olalekan Olasehinde, Olukayode Arowolo, Adewale Adisa, Oludolapo Afuwape, Aralola Olusanya, Aderemi Adegoke, Tomi Akinyemiju

10.1007/s10549-026-07986-6
View Publication

The value of innovation in breast cancer treatment: real option value of olaparib for first-line treatment of gBRCA-mutated HER2 negative metastatic breast cancer

Cynthia L. Gong, Mariana Chavez-MacGregor, Xiaoqing Xu, Leah Park, David Elsea, Sarah Katsandres, Kristen Migliaccio-Walle, David L. Veenstra

10.1007/s10549-026-07988-4
View Publication

Association of baseline tumor-infiltrating lymphocytes and cell-cycle regulation markers on prognosis and mortality in patients with advanced breast cancer according to tumor characteristics and treatment type: an observational study

Sauli Vuoti, Minna Saari, Janne Lahti, Kumar Narasimha, Kai Reinikainen

10.1007/s10549-026-07991-9
View Publication

Frequently asked questions

How long does it take to publish?

Articles are published online after receipt of corrected proofs following acceptance and typesetting.

Reformat to Breast Cancer Research and Treatment using Livewrite Premium

Is a cover letter required?

A cover letter is required at submission and must include at least three possible reviewers without conflicts of interest. Academic email addresses are highly recommended for suggested reviewers.

Reformat to Breast Cancer Research and Treatment using Livewrite Premium

What are the publication costs?

Open access APC: £2790.00 GBP / $4390.00 USD / €3290.00 EUR. Subscription publishing has no APC charges.

Reformat to Breast Cancer Research and Treatment using Livewrite Premium

Research Topics

Breast Cancer Treatment Studies Estrogen and related hormone effects HER2/EGFR in Cancer Research Breast Lesions and Carcinomas BRCA gene mutations in cancer Cancer Risks and Factors Global Cancer Incidence and Screening Cancer Treatment and Pharmacology Advanced Breast Cancer Therapies Cancer Cells and Metastasis Breast Implant and Reconstruction Cancer survivorship and care Cancer Genomics and Diagnostics Cancer-related Molecular Pathways DNA Repair Mechanisms Monoclonal and Polyclonal Antibodies Research Metabolism, Diabetes, and Cancer Digital Radiography and Breast Imaging Male Breast Health Studies Genetic factors in colorectal cancer Cancer Immunotherapy and Biomarkers Medical Imaging Techniques and Applications Cancer-related cognitive impairment studies Lymphatic System and Diseases Epigenetics and DNA Methylation

Related Journals

QO
Quality of Life Research Springer Science+Business Media
JO
Journal of Clinical Oncology LIPPINCOTT WILLIAMS & WILKINS
IJ
International Journal of Cancer WILEY
CE
Current Epidemiology Reports Springer Science+Business Media
AR
Annual Review of Cancer Biology ANNUAL REVIEWS
JO
Journal of Gastroenterology Springer Science+Business Media